ABSTRACT me incision of DNA at apurinic/apyrimidinic sites (AP-sites) by chloro-6-methoxy-2 ((adenyl-9)-ll)-4,8 diazadecyl )amino-9 acridine (Ade-Z-Acr), a 9-aminoacridine linked to an adenine, at nanomolar concentrations is described. Moreover, this drug, Ade-Z-Acr, is one of the most efficient drugs which cleaves DNA at AP-sites. The high activity is the result of the composition of the drug, since the individual components have no incising activity in the concentration range studied. The termini left by the Ade-Z-Acr molecule are a 3'deoxyribose and a 5'nucleotide. The termini and the inability of the Ade-Z-Acr to incise DNA with reduced AP-sites suggest that the mechanism of cleavage is p-elimi nation.
INTRODUCTION
Apurinic/apyrimidinic sites (AP-sites) are created by different mechanisms such as spontaneous depurination or treatment with X-ray or ultraviolet radiation (1). In addition, in vivo, physiological repair of altered DNA bases by DNA glycosylases also creates AP-sites (2, 3) . Therefore, since APsites are believed to alter processes associated with DNA replication (4, 5) , the repair of AP-sites in DNA is a critical cellular activity.
Previously we have studied the properties of AP endonucleases (6) and agents which mimic DNA endonuclease activity (7) . One series of drugs which incise DNA at AP-sites, the ellipticines, has demonstrated effectiveness clinically in combination chemotherapy (8) (9) (10) (11) (12) . The activity of the ellipticines used in combination chemotherapy may result from binding to DNA at AP-sites which may subsequently inhibit mechanisms of repair at these sites (10) . Thus, to further evaluate the role of AP-sites in vitro and j£ vivo, we synthesized a series of molecules with subtle changes in structure to act as inhibitors of AP-endonuclease activity (13) . In this study, we coupled a 9-aminoacridine with an adenine using different linking chains to create molecules with intercalating properties which specifically recognize AP-sites. However, in evaluating the binding of these molecules to DNA at AP-sites, we discovered that chloro-6 methoxy-2 ((adenyl-9)-ll)-4,8 diazadecyl) amino-9 acridine (Ade-Z-Acr) incises DNA specifically at AP-sites, and that moreover, this cleavage of DNA occurs at nanomolar concentrations of this compound. Additionally, we found that the coupling of the two functional groups by a specific linker enhances the ability of the components to incise DNA at low concentrations. We also determined the termini following cleavage by Ade-Z-Acr and suggest a mechanism for the catalysis. After the addition at 30 min., the reaction was incubated for another lh. The reduced ONA was purified by microdialysis followed by precipitation with ethanol.
MATERIALS AND METHODS

Enzymes
RESULTS
Ade-Z-Acr cleaves specifically at AP-sites The molecules shown in Fig. 1 , were originally designed as potential inhibitors of AP-endonucleases. The competition assays designed to test that hypothesis, however, showed that these molecules did not inhibit the AP-endonucl eases A and B from Micrococcus luteus or the AP-endonuclease activity of exonuclease III from E. coli (data not shown). However, the control reaction containing only Ade-Z-Acr revealed that the AP-pBR322 DNA was incised. Since none of the other molecules originally designed as inhibitors showed this activity, we investigated the ability of the Ade-Z-Acr to incise the DNA at AP sites. We prepared pBR322 molecules with different amounts of AP-sites by heating the pBR322 DNA at 70°C as a function of time. The DNAs with different amounts of AP-sites were then incubated in the presence of Ade-Z-Acr. The number of AP-sites was calibrated using the endonuclease activity of Exo III which cleaves DNA at AP-sites. Following the incubation, the reactions were stopped, and the DNA was electrophoresed to quantify the supercoiled and nicked species. Fig. 2 shows that as the time of incubation at 70°C of the pBR322 DNA increases, the number of AP-sites in the DNA increases as indicated by Exo III cleavage. As the number of AP-sites increases, cleavage by Ade-Z-Acr generates the same number of nicked species as incision by Exo III. Therefore, the Ade-Z-Acr reaction is consistent with recognition and cleavage at AP-sites.
Dependence of Ade-Z-Acr incision of AP-pBR322 DNA on concentration, ionic strength, and supercoiling
To determine the efficiency of the incising agent, we titrated the Ade-Z-Acr against a constant amount of AP-pBR322 DNA. The curve in Fig. 3 shows cleavage of AP-pBR322 DNA by Ade-Z-Acr. This curve demonstrates that there is significant incision of the DNA at AP-sites even at 20 nM concentrations.
In addition to the influence of the concentration of the incising agents, the incision of AP-DNA using Ade-Z-Acr was studied as a function of ionic strength and supercoiling. When the cleavage of AP-pBR322 DNA was performed at concentrations of NaCl from 2 nM to 100 mM there was no change These two other molecules, which are the components of the Ade-Z-Acr, show no incising activity in the nanomolar range. Ade-Z-Acr, however, has an activity at least 100 times higher than its components. Additionally, the other molecules investigated which couple the adenine and acridine through aliphatic chains (Ade-C n -Acr) do not display any enhanced activity to cleave DNA at APsites (data not shown). Therefore, the data in the three first sections have shown that Ade-Z-Acr 1) cleaves DNA specifically at AP-sites, 2) is one of the most efficient compounds known for incising DNA at AP-sites, and 3) has a unique composition of an adenine, a 9-aminoacridine and a linker which confers the ability to cleave the DNA at AP-sites.
Determination of the termini following incision by Ade-Z-Acr
In order to determine the nature of the termini formed by the Ade-Z-Acr cleavage at an AP-site, we used the specificity of enzymes for different types of termini. Fig. 4 displays a flow chart which presents the various possibilities of cleavage at AP-sites and methods to discern the type of incision observed for drugs or enzymes which cleave at such sites. As control molecules for these experiments we prepared a series of AP-DNAs containing the same number of AP-sites which were cleaved by Exo III and LysTrpLys which also incise DNA at AP-sites. The termini generated by cleaving with these two agents have been well characterized.
If an incision at an AP-site produced a molecule with a 5' OH associated with a base, that site would be a substrate for kinasing using the polynucleotide kinase from bacteriophage T4. However, we were not able to directly kinase the DNA following cleavage by Ade-Z-Acr as shown in Table I . Thus the termini left by the Ade-Z-Acr does not correspond to that of a Class III agent.
The termini generated by Class I agents are characterized by removal of a 5'-phosphate by calf intestine phosphatase, followed by kinasing with the T4 polynucleotide kinase. The results of this experiment given in Table I indicate that the termini generated by Ade-Z-Acr have the same properties as the termini created by the LysTrpLys which is a Class I agent. AP-pBR322 DNA incised by Ade-Z-Acr or LysTrpLys and treated with phosphatase prior to kinase incorporate 32 P at the same level. The AP-pBR322 DNA cleaved by Exo III, however, incorporates the label at the same level as the control. Chart indicating the potential cleavage sites by endonucleolytic agents incising ONA at AP-sites and methods for the determination of the class of cleavage (23) . Examples of the agents producing the given incision are also indicated for Drosophilia AP-endonuclease I (24), T4 endo V : T4 UV endonuclease V (25), LysTrpLys (7), and the endonuclease activity of E. coli Exonuclease III (20) . T4 kinase : 5' polynucieotide kinase from bacteriophage T4, CIP : calf intestine phosphatase.
DNA Incised at AP-Site
Priming activity for E. coli DNA polymerase I nick translation at termini of incised DNA
To support the previous data, we followed the incorporation of [^]-dATP into incised AP-DNA by E. coli DNA polymerase I. Following incision by the Ade-Z-Acr, the DNA was directly assayed for Class II activity by treatment with DNA polymerase I. The experiment shown in the bottom line of indicates that AP-DNAs treated or not treated with Ade-Z-Acr are poor substrates for the DNA polymerase I. Subsequent treatment with bacterial alkaline phosphatase increases only slightly the amount of label incorporated. However, if the Ade-Z-Acr incised AP-DNA is treated with Exonuclease III, the level of incorporation increases to a level comparable to that of cleavage by Exonuclease III alone as seen in Fig. 5 . This set of experiments, therefore, confirms the results in the previous section which indicated that the Ade-ZAcr is a Class I cleavage agent which yields termini consisting of a 3'deoxyribose and a 5'phosphate nucleoside. Ade-Z-Acr does not cleave reduced AP-pBR322 DNA Since there are Class I agents which are also p-eli mi nation catalysts, we reduced the AP-pBR322 DNA with NaBH 4 and treated the DNA with the Ade-ZAcr to determine if the aldehyde function was necessary to observe cleavage. The Ade-Z-Acr, however, was not able to cleave the reduced AP-pBR322 DNA (data not shown). In a separate control reaction, the endonuclease activity of Exo III was able to cleave the reduced AP-pBR322 DNA. Thus, both the termini and the inability of the Ade-Z-Acr to cleave the reduced DNA are consistent with the Ade-Z-Acr acting as a p-eli mi nation catalyst.
DISCUSSION
This report has shown that Ade-Z-Acr is an effective agent for incision of DNA containing AP-sites at nanomolar concentrations, and therefore, Ade-Z- Acr represents one of the most active synthetic agents for the cleavage of DNA at AP-sites. The activity of this drug is dependent on the precise design, since the component molecules do not cleave the AP-DNA in the concentrations studied. This cleavage leaves termini which may be kinased at the 5'OH after treatment with a 5'phosphatase. The termini generated following cleavage and the inability of Ade-Z-Acr to cleave reduced AP-DNA suggest that Ade-Z-Acr is a p-elimination catalyst. Table II compares different agents which cleave DNA at AP-sites. The activities of the 9-aminoellipticine, and the LysTrpLys tripeptide are of approximately the same order of magnitude. The concentration dependence of cleavage by Ade-Z-Acr, however, indicates that this agent is more effective In each study the quantity of DNA, ionic strength, time, and temperature of incubation vary. The values given therefore are accurate for the best conditions in each study.
at cleaving AP-sites than the 9-aminoellipticine and at least a factor of 1000 greater than the 9-hydroxyel1ipticine.
The spermine and spermidine values in Table II indicate that although charge is important (the more positively charged spermine is more efficient in cleaving the DNA than spermidine), the charged amine function alone is not responsible for efficient cleavage of DNA at AP-sites.
In addition to the high activity manifested by the Ade-Z-Acr, the conditions for incision by Ade-Z-Acr are similar to that of the 9-aminoellipticine. There is not a strong ionic strength dependence of the Ade-Z-Acr cleavage. In contrast, the LysTrpLys cleavage must be performed at low ionic strength (7, 27, 28) to facilitate the ionic interaction of the tripeptide with the DNA. Without this interaction, the tripeptide does not cleave at APsites. In fact, at peptide concentrations greater than 1 x 10 M, the LysTrpLys itself inhibits the incision of DNA as a result of the high ionic strength. This reduced dependence on ionic strength may play a role in the high efficiency of cleavage at AP-sites, since the interaction of the tripeptide LysTrpLys and the intercalator Ade-Z-Acr with the DNA would be expected to be different. The cleavage by LysTrpLys is also supercoil dependent. In addition to the reduced dependence on ionic strength, the cleavage by Ade-Z-Acr is not as sensitive to supercoiling as that of the LysTrpLys. At native supercoil densities (the supercoil density as isolated from the cell), high concentrations of LysTrpLys (10 M) must be used to incise AP-pBR322 DNA which has a much lower native supercoil density than AP-PM2 DNA (7). In contrast, there is virtually no difference in the concentration of Ade-Z-Acr needed to incise AP-pBR322 or AP-PM2 DNA.
Two pieces of evidence strongly support p-elimination as the mechanism of Ade-Z-Acr cleavage of DNA at AP-sites. The first evidence is that the termini left by the cleavage are consistent with the cleavage by p-elimination catalysts such as LysTrpLys (7, 26) . The second piece of evidence supporting this mechanism is that the reduced AP-pBR322 DNA is not a substrate for the Ade-Z-Acr. This agrees with previous reports that the free aldehyde of the deoxyribose interacts with primary amines in the process of p-elimination (29) .
This report has introduced a new reagent for probing a specific type of defect in DNA structure. Previously, Dervan coupled a propidium moiety and an Fe-EDTA moiety to create a molecule which cleaves native DNA (30) . The molecule presented in this report, Ade-Z-Acr, however has a different target and cleaves DNA at a specific type of lesion : an AP-site. Additionally, the affinity of the Ade-Z-Acr for native DNA is of the same order of magnitude as ethidium bromide (31) which suggests that there is a specificity of cleavage which is not the result of a high binding constant to native DNA. Although the Ade-Z-Acr effects a cleavage specifically at AP-sites using p elimination, the exact mode of action is still speculative. We hope that this molecule will prove useful in the study of AP-sites and AP-endonucleases.
